In this study, obese patients showed increased HSPA12A expression in WAT, while deficiency of HSPA12A in mice ameliorated HFD-induced obesity, hyperlipidemia and hyperglycemia. The gene discussed is HSPA12A; the disease is obesity due to melanocortin 4 receptor deficiency.